event,time
53 years old ,0
    male ,0
    visited the emergency room ,0
    productive cough ,-24
    fever ,-24
    chills ,-24
    30-pack/year history of cigarette smoking ,0
    consumed alcohol in moderation ,0
    treated for community-acquired pneumonia 2 years prior ,-17520
    acutely ill appearance ,0
    blood pressure 82/46 mmHg ,0
    respiratory rate 22 breaths per minute ,0
    pulse rate 120 beats per minute ,0
    body temperature 40â„ƒ ,0
    regular heart rhythm ,0
    coarse breathing sounds ,0
    crackles on the right lower lung field ,0
"    white blood cell count 11,500/mm3 ",0
    neutrophils 86.1% ,0
    lymphocytes 11.5% ,0
    monocytes 1.9% ,0
    eosinophils 0.2% ,0
    hemoglobin 14.4 g/dL ,0
"    platelet count 188,000/mm3 ",0
    C-reactive protein 1.28 mg/dL ,0
    pH 7.47 ,0
    pCO2 22.4 mmHg ,0
    pO2 52.5 mmHg ,0
    HCO3- 16 mmol/L ,0
    O2 saturation 89% ,0
    BUN/Cr 9/2.05 mg/dL ,0
    serum sodium 139 mmol/L ,0
    serum potassium 4.1 mmol/L ,0
    serum chloride 105 mmol/L ,0
    urine sodium 19 mmol/L ,0
    urine Cr 222.31 mg/dL ,0
    fractional excretion of sodium 0.1% ,0
    moderate patchy consolidation in the right lower lobe ,0
    presumptive diagnosis of sepsis caused by community-acquired pneumonia ,0
    septic shock ,0
    central line catheter insertion ,0
    fluid resuscitation ,0
    oxygen administered via nasal cannula ,0
    blood culture ,0
    sputum culture ,0
    urine culture ,0
    empiric piperacillin/tazobactam ,0
    ciprofloxacin injection ,0
    admission to intensive care unit ,0
    APACHE II score 25 ,0
    low blood pressure persisted ,0
    norepinephrine administration ,0
    vasopressin administration ,0
    respiratory distress worsened ,16
    acute respiratory failure ,16
    arterial blood gas analysis pH 7.085 ,16
    arterial blood gas analysis pCO2 61.4 mmHg ,16
    arterial blood gas analysis HCO3C 19 mmol/L ,16
    intubation ,16
    mechanical ventilation FiO2 1.0 ,16
    positive end expiratory pressure 14 cmH2O ,16
    hypoxia persisted ,16
    respiratory acidosis deteriorated ,16
    metabolic acidosis deteriorated ,16
    follow-up arterial blood gas analysis pH 7.096 ,24
    follow-up arterial blood gas analysis pCO2 63.7 mmHg ,24
    follow-up arterial blood gas analysis pO2 77.6 mmHg ,24
    follow-up arterial blood gas analysis HCO3C 20 mmol/L ,24
    follow-up arterial blood gas analysis O2 saturation 89% ,24
    exacerbated consolidation in the right lung field ,24
    patchy opacities in the left lower lobe ,24
    antibiotics switched to meropenem ,24
    antibiotics switched to teicoplanin ,24
    oliguria ,28
    acute kidney injury deteriorated ,28
    BUN/Cr 26/3.66 mg/dL ,28
    continuous renal replacement therapy ,28
    septic shock persisted ,36
    acute respiratory failure persisted ,36
    cardiac arrest ,36
    cardiopulmonary resuscitation ,36
    patient expired ,36
    Acinetobacter baumannii identified in sputum culture ,36
    Acinetobacter baumannii identified in blood cultures ,36
    bacterial susceptibility to piperacillin/tazobactam ,36
    bacterial susceptibility to ceftazidime ,36
    bacterial susceptibility to cefepime ,36
    bacterial susceptibility to imipenem ,36
    bacterial susceptibility to meropenem ,36
    bacterial susceptibility to gentamicin ,36
    bacterial susceptibility to tobramycin ,36
    bacterial tolerance to ampicillin ,36
    bacterial tolerance to amoxacillin/clavulanic acid ,36
    bacterial tolerance to cafalotin ,36
    bacterial tolerance to cefoxitin ,36
    bacterial tolerance to trimethoprim/sulfamethoxazole ,36
    bacterial moderate tolerance to cefotaxime ,36
    bacterial moderate tolerance to levofloxacin ,36
